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Introduction

Results

Discussion

Hidradenitis suppurativa is a complicated, chronic inflammatory
dermatologic condition characterized by comedone-like follicular
inclusions. Although the exact underlying mechanism of disease
is still disputed, leading theories suggest apocrine gland or
pilosebaceous unit involvement. Clinically, the disease is manifest
by the development of painful nodules, abscesses, sinus tracts,
and hypertrophic scarring of the skin. Hidradenitis may occur
anywhere on the body but is most common at the intertriginous
zones of the axillary, inframammary, inguinal, and perineal skin.
Risk factors for the development of hidradenitis include smoking,
obesity, and female sex and there is a higher incidence in African
Americans.

In total, 401 operative sites for 189 operations of 103 individual
patients were reviewed. The average patient age was 35.0 years.
At time of operation, 87 patients were current smokers, 18 had
a remote smoking history, 33 had diabetes mellitus, and 34 had
hypertension. There were 201 closures performed by primary
closure technique, 193 by local flap, and 7 by skin grafting. There
were no incidences of DVT, PE, or transfusion requirement for any
patient.

The aim of this project was to identify a superior closure technique
based on post-operative complication rates for the three chief
closure methods at Lehigh Valley Health Network. After the review
of 401 operative sites for 103 patients, we have shown that skin
grafting is superior to primary and flap closure in our patient
population based on lower recurrence, wound dehiscence, and
superficial SSI rates (Table 1). However, the small number of skin
graft reconstruction cases was small compared to the two other
methods. Our complication rate findings are consistent with other
previous investigations10,11,18 and add to the body of evidence
that suggests a shift in the surgical treatment paradigm in favor of
skin grafting for severe and refractory hidradenitis.

Treatment of the disease is exceptionally challenging and consists
of both non-surgical and surgical options. Conservative measures
are generally indicated for earlier stage disease and consist of
antibiotics, glucocorticoids, and retinoids, among others. Surgical
intervention is indicated for severe or refractory disease and is
the only definitive option for cure. When surgery is performed,
the local excision of diseased tissue often results in a large,
contaminated defect that requires closure and reconstruction to
preserve both function and cosmesis. Reconstructive methods
include closure by secondary intention, primary intention, skin
grafting, and fasciocutaneous and myocutaneous flaps. The body
of literature on the surgical treatment shows no consensus on
a superior closure technique. The present study seeks to build
upon this knowledgebase by considering three possible surgical
reconstructive options and all of their significant complications.

The sites closed by primary intention had rates of 27.36%,
7.46%, and 30.85% for wound dehiscence, superficial surgical
site infection (SSI), and total recurrence, respectively. Local flap
closures had rates of 43.01%, 8.81%, and 36.27% for wound
dehiscence, superficial SSI, and total recurrence, respectively. For
the skin graft closures, only 1 site (14.29%) experienced wound
dehiscence and 1 site superficial SSI. There were no episodes of
recurrence for skin graft closures, but 3 sites experienced partial
graft loss that required some healing by secondary intention.
Partial graft loss was defined as 10-90% loss based on national
complication database criteria. Table 1 below shows the collective
findings for the recorded complications and Figure 1 depicts the
three most prevalent complications.
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Figure 1. Complication rates of the three most prevalent complications for primary, local flap,
and skin graft closures.

In addition to providing valuable treatment and outcomes data
for the Lehigh Valley Health Network patient population, the data
recorded in this study can also be used in the future for both
academic and quality improvement purposes. Perhaps most evident
is that the data reported above may now be compared to other
similar studies in hidradenitis surgical outcomes research. Also,
as mentioned above, the data serves as further evidence that skin
grafting should be considered before primary and local flap closure,
at least in consenting patients with appropriate wound bed. Tracking
Operations and Outcomes for Plastic Surgeons (TOPS) is a national
database program launched in 2002 by the American Society of
Plastic Surgeons that strives to collect self-reported outcomes data
as a practice management, research, and advocacy tool for the
specialty and its patients. By submitting the data reported here to
TOPS in the future, it could be compared to the national database’s
outcomes for these procedures. Indeed, one of the goals of TOPS is
to help physician leaders and plastic surgeons determine national
benchmarks and practice patterns and our data could be a valuable
piece of that process.

SELECT Integration

Conclusions

As the surgical treatment of hidradenitis continues to be
investigated, the primary goal is to improve patient outcomes
by having fewer complications. Indeed, this applies directly
to the “Better Care” aspect of The Triple Aim, which we have
studied directly within the Health Systems domain of the SELECT
curriculum. In general, complications of any surgical operation
are financially taxing to the healthcare system and result in
decreased value for patients over the course of their treatment. As
hidradenitis may affect up to 4% of the population,2 determining
a best practice closure method following excision can be of
substantial savings to the health system—the “Better Cost”
principle of The Triple Aim—even if surgical intervention is only
reserved for those patients with later stage disease. A consensus
within the plastic surgery field on superior method of closure has
the potential to minimize all of the complications considered in the
present study, resulting in the liberation of healthcare resources
including time, personnel, and money for devotion to other
endeavors.

The data reported in this study show that superficial wound
dehiscence, superficial SSI, and recurrence are the major postoperative complications in patients that undergo surgical excision
of hidradenitis with either primary or flap closure. Skin grafting
for wound closure appears to have lower rates of these three
complications, but the number of operative sites closed by this
method in the studied patient population was small. These
results further support the idea that skin grafting after excision of
hidradenitis, at least for resultant wounds with appropriate wound
beds, is superior to primary intention and local flap reconstruction
methods. Future studies with a larger number of skin graft closure
cases are required for validation of this study and to suggest a shift
in surgical treatment methodology.

Total Recurrence

The current study aims to identify a superior closure technique for
the surgical treatment of hidradenitis suppurativa based on the
most clinically significant complication rates. Excision of diseased
hidradenitic tissue results in a soft tissue defect that must be
closed using one of a variety of reconstructive options. Here, we
consider the post-operative complication rates of three closure
methods performed at Lehigh Valley Health Network—primary
closure, local flap closure, and skin grafting—to both contribute
to the body of literature on the topic and propose a best closure
method.

Methodology
A retrospective chart review of all patients who underwent
surgical reconstruction for hidradenitis suppurativa at Lehigh
Valley Health Network from January 1, 2004 to December 31,
2014 was performed. First, all patient records with a diagnosis
of “Hidradenitis Suppurativa” as identified by ICD-9 code
705.83 were gathered within the EPIC electronic medical record
database. To ensure only those patients who underwent surgical
excision were included, the CPT codes 11451, 11450, 11462,
11470, 11463, and 11471 were required to be listed in the
chart. Patients were then stratified according to type of surgical
reconstruction performed, including primary closure, skin graft,
or local flap. Data was tabulated in a secure Microsoft Excel
spreadsheet for simpler analysis.
Patient charts were reviewed for documentation of all relevant
complications for each individual operation and operative site:
DVT, PE, seroma, hematoma, wound dehiscence, superficial
surgical site infection (SSI), flap loss, graft loss, transfusion
requirement, unplanned post-operative emergency department
(ED) visit, unplanned post-operative hospital admission,
unplanned post-operative return to the operating room (OR), and
recurrence at the operative site within and after one year of the
operation.

36.27%

Table 1. 30-day complication rates for all considered complications for primary, local flap, and
skin graft closure.
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Problem Statement

Several limitations of this project presented themselves during the
data collection and analysis process. As aforementioned, the review
of each patient record required the assessment of three charts,
including one paper chart and two electronic medical records.
This introduced a significant challenge in collection of data points
as relevant data was located in any or all of the record types. It
also substantially prolonged the time required for collection. Next,
determining whether or not a hidradenitis lesion represents residual
or recurrent hidradenitis can be challenging for clinicians and some
charts were not precise in stating whether or not a given lesion
was residual, remaining diseased tissue from a prior incomplete
excision, or recurrent, a true new lesion. The common waxing and
waning course of hidradenitis further complicates this issue for
clinicians.

40%
35%
30%

Primary Closure

25%

Local Flap

20%

Skin Graft

15%
10%
5%
0%

Superﬁcial SSI

Wound Dehiscence

Total Recurrence

Lastly, this project is directly relevant to patient-centered care.
Presently, reconstructive options for patients following excision
may be dependent on individual surgeon preference or institution
policy. Subsequently, patients may not always be receiving the
best evidence-based reconstructive options. By adding to the
body of literature that suggests skin grafting is superior to other
methods, the plastic surgery field may be one step closer to
confirming this reconstruction method as the best choice for
patient outcomes and surgeons will be able to offer patients
choices with greater context.
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